Cytomegalovirus pUL97 Kinase Inhibitor [EPC]

Cytomegalovirus pUL97 Kinase Inhibitor [EPC] was reported 2469 times

Drugs of the Cytomegalovirus pUL97 Kinase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ADENOVIRUS ENCEPHALOMYELORADICULITIS 1 0.5000
1 HAIR-THREAD TOURNIQUET SYNDROME 1 0.5000
2 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
3 INTERLEUKIN LEVEL 1 0.3333
4 CYTOMEGALOVIRUS TEST NEGATIVE 2 0.2500
5 CONGENITAL THYMUS ABSENCE 1 0.2000
6 MERKEL CELL POLYOMAVIRUS INFECTION 1 0.1250
7 AUTOIMMUNE PANCYTOPENIA 10 0.1099
8 VIRAL LOAD ABNORMAL 10 0.0571
9 VIRAL LOAD DECREASED 8 0.0548
10 SYSTEMIC BACTERIAL INFECTION 4 0.0533
11 COMPLICATIONS OF INTESTINAL TRANSPLANT 1 0.0526
12 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 3 0.0508
13 DIASTEMA 1 0.0500
14 HUMAN T-CELL LYMPHOTROPIC VIRUS INFECTION 1 0.0417
15 DRUG RESISTANCE MUTATION 7 0.0393
16 CYTOMEGALOVIRUS INFECTION REACTIVATION 156 0.0353
17 BARTONELLA TEST POSITIVE 1 0.0345
18 VIRAL LOAD INCREASED 128 0.0329
19 CYTOMEGALOVIRUS TEST POSITIVE 58 0.0325
20 PARVOVIRUS INFECTION 13 0.0322
21 CORYNEBACTERIUM SEPSIS 2 0.0303
22 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 9 0.0302
23 COMPLICATIONS OF TRANSPLANTED PANCREAS 1 0.0286
24 ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC 2 0.0267
25 INFECTIVE PERICARDIAL EFFUSION 1 0.0222
26 CYTOMEGALOVIRUS VIRAEMIA 88 0.0198
27 ENCEPHALITIS CYTOMEGALOVIRUS 8 0.0183
28 GENETIC POLYMORPHISM 1 0.0175
29 SEPTIC ENCEPHALOPATHY 3 0.0174
30 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 3 0.0173
31 HEPATITIS B DNA ASSAY POSITIVE 2 0.0156
32 GRAFT VERSUS HOST DISEASE ORAL 1 0.0156
33 DRUG LEVEL 1 0.0147
34 T-LYMPHOCYTE COUNT DECREASED 10 0.0147
35 HAEMATOLOGICAL NEOPLASM 1 0.0145
36 CAMPYLOBACTER TEST POSITIVE 1 0.0132
37 HUMAN HERPESVIRUS 8 INFECTION 8 0.0131
38 TRANSPLANTATION COMPLICATION 5 0.0119
39 CORYNEBACTERIUM BACTERAEMIA 1 0.0118
40 POLYMERASE CHAIN REACTION POSITIVE 4 0.0115
41 CYTOMEGALOVIRUS INFECTION 189 0.0114
42 TASTE DISORDER 229 0.0113
43 PNEUMOCYSTIS JIROVECII INFECTION 13 0.0109
44 CYTOMEGALOVIRUS CHORIORETINITIS 21 0.0108
45 PARVOVIRUS B19 INFECTION 9 0.0101
46 PNEUMONIA CYTOMEGALOVIRAL 19 0.0098
47 VIRAEMIA 13 0.0094
48 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 13 0.0092
49 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 2 0.0087
50 LUMBAR PUNCTURE ABNORMAL 1 0.0086
51 LARYNGEAL NEOPLASM 1 0.0082
52 ONYCHOMALACIA 1 0.0080
53 DRUG RESISTANCE 184 0.0072
54 HYPERCAPNIC COMA 1 0.0070
55 CYTOMEGALOVIRUS COLITIS 15 0.0065
56 COMPLICATIONS OF TRANSPLANTED LUNG 2 0.0065
57 INFECTIVE GLOSSITIS 1 0.0064
58 CARBON DIOXIDE ABNORMAL 2 0.0064
59 GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0063
60 MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL 1 0.0062
61 NEPHROANGIOSCLEROSIS 1 0.0062
62 BLOOD CHLORIDE ABNORMAL 1 0.0062
63 HYPERCREATINAEMIA 2 0.0060
64 INTESTINAL TUBERCULOSIS 1 0.0057
65 BRONCHIOLITIS OBLITERANS SYNDROME 1 0.0057
66 CYTOMEGALOVIRUS HEPATITIS 2 0.0056
67 MENINGOENCEPHALITIS VIRAL 1 0.0056
68 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
69 VIRAL TEST POSITIVE 2 0.0055
70 BLOOD ALKALINE PHOSPHATASE 1 0.0054
71 HAEMATOPOIETIC NEOPLASM 1 0.0053
72 CYSTITIS VIRAL 2 0.0052
73 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 1 0.0051
74 BIOPSY KIDNEY ABNORMAL 1 0.0051
75 PANCREAS TRANSPLANT REJECTION 1 0.0050
76 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
77 AUTOINFLAMMATORY DISEASE 1 0.0047
78 IMMOBILISATION SYNDROME 1 0.0047
79 PRODUCT DISTRIBUTION ISSUE 43 0.0046
80 CYTOMEGALOVIRUS GASTROENTERITIS 1 0.0046
81 LUNG TRANSPLANT REJECTION 3 0.0045
82 MONOCYTE COUNT ABNORMAL 1 0.0045
83 ADENOVIRUS INFECTION 13 0.0045
84 BRONCHOSCOPY 1 0.0042
85 PRODUCT AFTER TASTE 4 0.0042
86 EAR NEOPLASM MALIGNANT 1 0.0042
87 CANCER IN REMISSION 1 0.0041
88 BLOOD CREATINE ABNORMAL 2 0.0041
89 KLEBSIELLA URINARY TRACT INFECTION 1 0.0038
90 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
91 CHRONIC MYELOID LEUKAEMIA RECURRENT 2 0.0037
92 MORAXELLA INFECTION 1 0.0036
93 BLOOD MAGNESIUM ABNORMAL 2 0.0036
94 DYSGEUSIA 268 0.0036
95 ORTHOSIS USER 1 0.0036
96 MINERAL DEFICIENCY 1 0.0036
97 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
98 GRAFT VERSUS HOST DISEASE 24 0.0033
99 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 11 0.0033
100 VENOOCCLUSIVE DISEASE 8 0.0032
101 BONE MARROW TRANSPLANT 6 0.0032
102 EYE INFECTION VIRAL 1 0.0031
103 RENAL TRANSPLANT FAILURE 3 0.0030
104 LUNG PERFORATION 1 0.0030
105 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
106 HEART TRANSPLANT REJECTION 3 0.0029
107 POLYOMAVIRUS VIRAEMIA 3 0.0028
108 DIALYSIS RELATED COMPLICATION 1 0.0028
109 COMPLICATIONS OF TRANSPLANTED LIVER 1 0.0028
110 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
111 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
112 LOWER URINARY TRACT SYMPTOMS 1 0.0028
113 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0027
114 OPPORTUNISTIC INFECTION 5 0.0027
115 HEPATITIS B CORE ANTIBODY POSITIVE 1 0.0027
116 VENOOCCLUSIVE LIVER DISEASE 13 0.0026
117 LIPID METABOLISM DISORDER 1 0.0026
118 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0026
119 AORTIC RUPTURE 1 0.0026
120 LOWER RESPIRATORY TRACT INFECTION FUNGAL 1 0.0026
121 FULL BLOOD COUNT INCREASED 3 0.0025
122 AMMONIA ABNORMAL 1 0.0025
123 HAEMATOCRIT ABNORMAL 3 0.0024
124 INSURANCE ISSUE 37 0.0024
125 IMMUNE-MEDIATED RENAL DISORDER 1 0.0024
126 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0024
127 ENZYME LEVEL INCREASED 2 0.0024
128 HEARING AID USER 1 0.0023
129 BLOOD CREATININE ABNORMAL 8 0.0023
130 HERPES SIMPLEX 15 0.0023
131 ASPERGILLUS INFECTION 15 0.0023
132 CONGESTIVE HEPATOPATHY 1 0.0022
133 ANAEMIA OF CHRONIC DISEASE 2 0.0022
134 IMMUNE THROMBOCYTOPENIA 10 0.0022
135 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0022
136 THERAPEUTIC PROCEDURE 3 0.0021
137 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
138 BLOOD UREA ABNORMAL 2 0.0021
139 MEAN CELL VOLUME ABNORMAL 1 0.0021
140 CRANIAL NERVE PARALYSIS 1 0.0021
141 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
142 PATHOGEN RESISTANCE 19 0.0021
143 BLAST CELLS PRESENT 1 0.0021
144 NOROVIRUS INFECTION 3 0.0021
145 PYURIA 2 0.0020
146 DERMATITIS INFECTED 1 0.0020
147 INFECTIOUS PLEURAL EFFUSION 3 0.0020
148 BREAST ABSCESS 2 0.0020
149 GENOTYPE DRUG RESISTANCE TEST POSITIVE 2 0.0019
150 BLOOD ALBUMIN ABNORMAL 1 0.0019
151 CRYPTOSPORIDIOSIS INFECTION 1 0.0019
152 FUNGAEMIA 3 0.0019
153 HUMAN POLYOMAVIRUS INFECTION 1 0.0019
154 AUTOIMMUNE HEPATITIS 13 0.0019
155 ACUTE MYELOID LEUKAEMIA RECURRENT 4 0.0019
156 STREPTOCOCCAL BACTERAEMIA 2 0.0018
157 CLAUSTROPHOBIA 2 0.0018
158 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
159 EPSTEIN-BARR VIRAEMIA 2 0.0018
160 CYTOPENIA 22 0.0018
161 INTRACRANIAL HAEMATOMA 1 0.0018
162 BACTERIURIA 1 0.0018
163 RETINITIS 3 0.0017
164 MENTAL DISABILITY 1 0.0017
165 INABILITY TO AFFORD MEDICATION 17 0.0017
166 HISTOPLASMOSIS 3 0.0017
167 MULTIMORBIDITY 2 0.0017
168 GRUNTING 1 0.0017
169 RENAL TUBULAR INJURY 2 0.0016
170 THROMBOTIC MICROANGIOPATHY 16 0.0016
171 TRANSPLANT FAILURE 4 0.0016
172 MEDICAL DEVICE SITE INFECTION 1 0.0016
173 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
174 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 12 0.0016
175 KLEBSIELLA INFECTION 8 0.0016
176 BLOOD CREATINE INCREASED 7 0.0016
177 HEPATIC INFECTION 2 0.0016
178 HAEMOGLOBIN ABNORMAL 10 0.0016
179 HYPERMAGNESAEMIA 1 0.0015
180 MYELOPROLIFERATIVE NEOPLASM 1 0.0015
181 BLOOD POTASSIUM ABNORMAL 4 0.0015
182 HEPATITIS B DNA INCREASED 1 0.0015
183 BK VIRUS INFECTION 5 0.0015
184 HOSPITALISATION 223 0.0014
185 NEUTROPHIL COUNT ABNORMAL 4 0.0014
186 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
187 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
188 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
189 ANTIBODY TEST ABNORMAL 1 0.0014
190 BITE 1 0.0014
191 ESCHERICHIA SEPSIS 4 0.0014
192 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
193 RED BLOOD CELL COUNT ABNORMAL 2 0.0014
194 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0013
195 VASCULAR DEVICE INFECTION 6 0.0013
196 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
197 PNEUMONIA PSEUDOMONAL 2 0.0013
198 ALLERGIC COUGH 1 0.0013
199 NEUROLOGICAL DECOMPENSATION 3 0.0013
200 RENAL FUNCTION TEST ABNORMAL 6 0.0013
201 RHINOVIRUS INFECTION 5 0.0013
202 CRITICAL ILLNESS 1 0.0013
203 DRUG TOLERANCE INCREASED 1 0.0013
204 WHITE BLOOD CELL COUNT ABNORMAL 8 0.0013
205 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
206 TRANSPLANT REJECTION 10 0.0012
207 ENTEROCOCCAL SEPSIS 1 0.0012
208 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 1 0.0012
209 AUTOIMMUNE DISORDER 12 0.0012
210 HAEMATOLOGICAL INFECTION 3 0.0012
211 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
212 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 6 0.0012
213 PRODUCT AVAILABILITY ISSUE 27 0.0012
214 LEUKAEMIA RECURRENT 2 0.0012
215 ALLERGIC SINUSITIS 1 0.0012
216 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
217 PSEUDOMONAL SEPSIS 2 0.0011
218 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
219 CANDIDA SEPSIS 1 0.0011
220 BLOOD MAGNESIUM INCREASED 1 0.0011
221 BACTERAEMIA 13 0.0011
222 BODY TEMPERATURE ABNORMAL 2 0.0011
223 AGEUSIA 27 0.0011
224 ADVERSE FOOD REACTION 1 0.0011
225 KLEBSIELLA BACTERAEMIA 1 0.0011
226 NEUTROPENIC INFECTION 1 0.0010
227 KIDNEY TRANSPLANT REJECTION 5 0.0010
228 GUILLAIN-BARRE SYNDROME 5 0.0010
229 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
230 HAEMOPHILUS INFECTION 1 0.0010
231 BACTERIAL INFECTION 19 0.0010
232 HYPERVOLAEMIA 5 0.0010
233 MUCOSAL DISORDER 1 0.0010
234 HAEMOLYTIC ANAEMIA 9 0.0010
235 PLATELET COUNT ABNORMAL 6 0.0010
236 MUCOSAL ULCERATION 1 0.0010
237 DILATED CARDIOMYOPATHY 1 0.0010
238 LYMPHOPENIA 14 0.0010
239 DROWNING 1 0.0010
240 NEPHROPATHY TOXIC 11 0.0010
241 ENTEROCOCCAL BACTERAEMIA 1 0.0009
242 FULL BLOOD COUNT DECREASED 19 0.0009
243 BLOOD SODIUM ABNORMAL 1 0.0009
244 PULMONARY TUBERCULOSIS 4 0.0009
245 HYPERPHOSPHATAEMIA 2 0.0009
246 NOSOCOMIAL INFECTION 2 0.0009
247 NEPHRITIS 3 0.0009
248 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
249 KLEBSIELLA SEPSIS 1 0.0009
250 PRODUCT TASTE ABNORMAL 12 0.0009
251 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
252 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
253 CARBON DIOXIDE DECREASED 1 0.0009
254 ESCHERICHIA BACTERAEMIA 2 0.0008
255 GROIN ABSCESS 1 0.0008
256 LEUKAEMIA 8 0.0008
257 TRANSPLANT 2 0.0008
258 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
259 CHRONIC RESPIRATORY FAILURE 1 0.0008
260 ENTEROCOCCAL INFECTION 4 0.0008
261 PSEUDOMONAS INFECTION 7 0.0008
262 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
263 LARGE INTESTINE INFECTION 1 0.0008
264 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
265 STEM CELL TRANSPLANT 2 0.0008
266 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
267 IMMUNOSUPPRESSION 7 0.0008
268 URINARY TRACT INFECTION BACTERIAL 2 0.0008
269 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 4 0.0008
270 BILIARY OBSTRUCTION 1 0.0008
271 FAILURE TO THRIVE 4 0.0008
272 RETINAL DISORDER 2 0.0008
273 APLASTIC ANAEMIA 4 0.0008
274 PNEUMONIA BACTERIAL 7 0.0008
275 OBLITERATIVE BRONCHIOLITIS 1 0.0008
276 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
277 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
278 GASTROENTERITIS NOROVIRUS 1 0.0008
279 WHITE BLOOD CELL DISORDER 2 0.0007
280 STEATORRHOEA 2 0.0007
281 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21 0.0007
282 PRODUCT PRESCRIBING ISSUE 16 0.0007
283 CLUSTER HEADACHE 1 0.0007
284 RENAL DISORDER 34 0.0007
285 PRODUCT USE ISSUE 136 0.0007
286 CHOLECYSTITIS INFECTIVE 2 0.0007
287 INCISIONAL HERNIA 1 0.0007
288 BLOOD TEST ABNORMAL 10 0.0007
289 RENAL TUBULAR DISORDER 2 0.0007
290 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
291 INTENSIVE CARE 1 0.0007
292 PNEUMATOSIS INTESTINALIS 2 0.0007
293 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
294 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
295 NORMOCYTIC ANAEMIA 1 0.0007
296 PANCYTOPENIA 38 0.0007
297 HYPOSMIA 1 0.0007
298 DRUG LEVEL INCREASED 11 0.0007
299 SUSPECTED OFF LABEL USE 3 0.0007
300 HIV INFECTION 2 0.0007
301 LEUKOPENIA 33 0.0007
302 MOUTH INJURY 1 0.0007
303 INTELLECTUAL DISABILITY 1 0.0007
304 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
305 MYELITIS 1 0.0006
306 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
307 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
308 BACTERIAL SEPSIS 2 0.0006
309 PAPILLOMA VIRAL INFECTION 1 0.0006
310 INJECTION RELATED REACTION 1 0.0006
311 NEAR DEATH EXPERIENCE 2 0.0006
312 ORGANISING PNEUMONIA 3 0.0006
313 SKIN INJURY 2 0.0006
314 BLOOD CALCIUM ABNORMAL 1 0.0006
315 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
316 SEPTIC SHOCK 26 0.0006
317 TONGUE ULCERATION 2 0.0006
318 FOOD AVERSION 1 0.0006
319 ENTERITIS INFECTIOUS 1 0.0006
320 BLOOD MAGNESIUM DECREASED 5 0.0006
321 PANCREATIC FAILURE 1 0.0006
322 LUNG TRANSPLANT 2 0.0006
323 LIVER TRANSPLANT REJECTION 1 0.0006
324 PNEUMONITIS 15 0.0006
325 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
326 ESSENTIAL HYPERTENSION 1 0.0005
327 VIRAL INFECTION 18 0.0005
328 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
329 INFECTED SKIN ULCER 1 0.0005
330 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
331 BLOOD BICARBONATE DECREASED 1 0.0005
332 HYPOPROTEINAEMIA 1 0.0005
333 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
334 EPIGASTRIC DISCOMFORT 2 0.0005
335 HYPOGEUSIA 1 0.0005
336 KIDNEY INFECTION 10 0.0005
337 PNEUMONIA FUNGAL 2 0.0005
338 GENE MUTATION 1 0.0005
339 EMPYEMA 1 0.0005
340 BLOOD PRESSURE ABNORMAL 10 0.0005
341 HYPOMAGNESAEMIA 7 0.0005
342 DEVICE RELATED SEPSIS 1 0.0005
343 CYSTITIS HAEMORRHAGIC 2 0.0005
344 CHOLANGITIS SCLEROSING 1 0.0005
345 HYPERPARATHYROIDISM 1 0.0005
346 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
347 PRODUCT DISPENSING ISSUE 2 0.0005
348 OLIGOMENORRHOEA 1 0.0005
349 IMMUNE SYSTEM DISORDER 6 0.0005
350 WALKING AID USER 3 0.0005
351 MIDDLE EAR EFFUSION 1 0.0005
352 GINGIVAL SWELLING 2 0.0005
353 ABDOMINAL ABSCESS 2 0.0005
354 CARDIAC FAILURE ACUTE 3 0.0004
355 BACTERIAL TEST POSITIVE 1 0.0004
356 LARGE INTESTINAL OBSTRUCTION 1 0.0004
357 MALNUTRITION 5 0.0004
358 GASTROINTESTINAL INFECTION 4 0.0004
359 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
360 DISTRIBUTIVE SHOCK 1 0.0004
361 RENAL IMPAIRMENT 37 0.0004
362 LICHENOID KERATOSIS 1 0.0004
363 ECCHYMOSIS 3 0.0004
364 FLAT AFFECT 1 0.0004
365 HYPERTRANSAMINASAEMIA 3 0.0004
366 DISCOURAGEMENT 1 0.0004
367 COVID-19 PNEUMONIA 5 0.0004
368 POST PROCEDURAL COMPLICATION 8 0.0004
369 MYELODYSPLASTIC SYNDROME 6 0.0004
370 HYPOPHOSPHATAEMIA 3 0.0004
371 BREATH SOUNDS ABNORMAL 2 0.0004
372 INFREQUENT BOWEL MOVEMENTS 1 0.0004
373 FLUID INTAKE REDUCED 2 0.0004
374 HYPERPARATHYROIDISM SECONDARY 1 0.0004
375 PAROSMIA 3 0.0004
376 WHITE BLOOD CELL COUNT DECREASED 43 0.0004
377 DRUG TOLERANCE 2 0.0004
378 BRAIN ABSCESS 1 0.0004
379 AMMONIA INCREASED 2 0.0004
380 ABDOMINAL INFECTION 1 0.0004
381 NOCARDIOSIS 1 0.0004
382 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
383 DISSEMINATED TUBERCULOSIS 1 0.0004
384 MEAN CELL VOLUME INCREASED 1 0.0004
385 AORTIC ARTERIOSCLEROSIS 1 0.0004
386 MALABSORPTION 2 0.0004
387 FULL BLOOD COUNT ABNORMAL 4 0.0004
388 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
389 BLOOD SODIUM INCREASED 1 0.0004
390 BLOOD POTASSIUM INCREASED 6 0.0004
391 ILLNESS 38 0.0004
392 LARGE INTESTINAL ULCER 1 0.0004
393 DEATH 317 0.0004
394 BLOOD CREATININE INCREASED 24 0.0004
395 GASTRIC PERFORATION 1 0.0004
396 IMPAIRED GASTRIC EMPTYING 5 0.0004
397 CLUMSINESS 1 0.0004
398 ASPIRATION 4 0.0004
399 ESCHERICHIA INFECTION 3 0.0004
400 ACUTE RESPIRATORY FAILURE 7 0.0004
401 DEAFNESS UNILATERAL 2 0.0004
402 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
403 HAEMOGLOBIN DECREASED 37 0.0004
404 INTRACRANIAL PRESSURE INCREASED 2 0.0004
405 ELECTRIC SHOCK SENSATION 1 0.0004
406 ENDOTRACHEAL INTUBATION 1 0.0004
407 DRUG TOLERANCE DECREASED 1 0.0004
408 NECK MASS 1 0.0004
409 NEUTROPENIA 48 0.0004
410 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
411 OXYGEN SATURATION ABNORMAL 1 0.0004
412 PERONEAL NERVE PALSY 2 0.0004
413 HAEMATOLOGICAL MALIGNANCY 1 0.0004
414 HYPERSOMNIA 10 0.0003
415 HERPES VIRUS INFECTION 2 0.0003
416 ENTEROCOLITIS 2 0.0003
417 ACUTE KIDNEY INJURY 53 0.0003
418 HYPERTONIC BLADDER 1 0.0003
419 ANOSMIA 5 0.0003
420 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
421 SEPSIS 38 0.0003
422 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
423 IMMUNODEFICIENCY 5 0.0003
424 ATYPICAL PNEUMONIA 1 0.0003
425 GANGRENE 2 0.0003
426 CENTRAL VENOUS CATHETERISATION 1 0.0003
427 LOSS OF EMPLOYMENT 1 0.0003
428 UROSEPSIS 3 0.0003
429 DIASTOLIC DYSFUNCTION 1 0.0003
430 AGRANULOCYTOSIS 6 0.0003
431 FLANK PAIN 3 0.0003
432 BLOOD CREATININE DECREASED 1 0.0003
433 EOSINOPHILIC PNEUMONIA 1 0.0003
434 PHOTOPSIA 2 0.0003
435 RED BLOOD CELL COUNT DECREASED 9 0.0003
436 BILE DUCT STONE 1 0.0003
437 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
438 COVID-19 55 0.0003
439 LIVER ABSCESS 1 0.0003
440 RENAL TUBULAR NECROSIS 3 0.0003
441 MYELOSUPPRESSION 11 0.0003
442 FUNGAL INFECTION 10 0.0003
443 INFECTION 43 0.0003
444 FEEDING DISORDER 6 0.0003
445 NEOPLASM RECURRENCE 1 0.0003
446 DRUG LEVEL DECREASED 3 0.0003
447 DIABETIC RETINOPATHY 1 0.0003
448 THERAPY INTERRUPTED 21 0.0003
449 APLASIA PURE RED CELL 1 0.0003
450 GASTROINTESTINAL DISORDER 26 0.0003
451 ENCEPHALITIS 2 0.0003
452 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
453 BLINDNESS UNILATERAL 4 0.0003
454 DRUG ERUPTION 5 0.0003
455 URINARY TRACT INFECTION 48 0.0003
456 RETINAL HAEMORRHAGE 2 0.0003
457 PLEURAL EFFUSION 17 0.0003
458 FAECES SOFT 2 0.0003
459 AMYLASE INCREASED 1 0.0003
460 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
461 NO ADVERSE EVENT 49 0.0003
462 HYDRONEPHROSIS 2 0.0003
463 EYE INFECTION 3 0.0003
464 REBOUND EFFECT 3 0.0003
465 CHEMOTHERAPY 1 0.0003
466 CATHETER SITE INFECTION 1 0.0003
467 BOWEL MOVEMENT IRREGULARITY 2 0.0003
468 PROCEDURAL COMPLICATION 2 0.0003
469 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
470 LYMPHOMA 4 0.0003
471 HYPOALBUMINAEMIA 2 0.0003
472 ACUTE MYELOID LEUKAEMIA 4 0.0003
473 FLUID RETENTION 13 0.0003
474 GASTROINTESTINAL INFLAMMATION 2 0.0003
475 PRODUCT USE COMPLAINT 4 0.0003
476 PNEUMOTHORAX 4 0.0003
477 HAEMATOCRIT DECREASED 5 0.0003
478 HYPERPHAGIA 1 0.0003
479 OBSTRUCTION 1 0.0003
480 BLOOD DISORDER 2 0.0002
481 ORGAN FAILURE 1 0.0002
482 ENCEPHALOPATHY 6 0.0002
483 EXTRAVASATION 1 0.0002
484 PRODUCT DOSE OMISSION ISSUE 71 0.0002
485 FEBRILE NEUTROPENIA 16 0.0002
486 PNEUMONIA 77 0.0002
487 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
488 MUSCLE FATIGUE 1 0.0002
489 RENAL INJURY 7 0.0002
490 FEBRILE BONE MARROW APLASIA 1 0.0002
491 OFF LABEL USE 206 0.0002
492 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
493 EATING DISORDER 5 0.0002
494 ABSCESS LIMB 1 0.0002
495 LUNG NEOPLASM 1 0.0002
496 RESPIRATORY FAILURE 17 0.0002
497 HORDEOLUM 1 0.0002
498 PYELONEPHRITIS 2 0.0002
499 URINE OUTPUT DECREASED 2 0.0002
500 ONYCHOMYCOSIS 1 0.0002
501 SARS-COV-2 TEST POSITIVE 3 0.0002
502 FATIGUE 176 0.0002
503 ANAEMIA 43 0.0002
504 ILEUS PARALYTIC 1 0.0002
505 FREQUENT BOWEL MOVEMENTS 6 0.0002
506 PAPILLOEDEMA 1 0.0002
507 DRUG INTERACTION 35 0.0002
508 HAEMOGLOBIN INCREASED 1 0.0002
509 DISEASE COMPLICATION 1 0.0002
510 EAR DISORDER 1 0.0002
511 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
512 RETINAL DETACHMENT 2 0.0002
513 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
514 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
515 HYPOCALCAEMIA 4 0.0002
516 CARDIAC TAMPONADE 1 0.0002
517 GASTROINTESTINAL TOXICITY 1 0.0002
518 APHAGIA 1 0.0002
519 PERIPHERAL SWELLING 32 0.0002
520 DIARRHOEA 133 0.0002
521 EAR PAIN 4 0.0002
522 ORAL HERPES 4 0.0002
523 INCORRECT DOSAGE ADMINISTERED 1 0.0002
524 INFLAMMATORY BOWEL DISEASE 2 0.0002
525 THERAPY CHANGE 2 0.0002
526 LABORATORY TEST ABNORMAL 6 0.0002
527 PANCREATIC DISORDER 1 0.0002
528 OEDEMA 11 0.0002
529 HOSPICE CARE 2 0.0002
530 MUCOUS STOOLS 1 0.0002
531 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
532 ABDOMINAL TENDERNESS 1 0.0002
533 UPPER LIMB FRACTURE 4 0.0002
534 PRESCRIBED UNDERDOSE 4 0.0002
535 HEPATIC FAILURE 6 0.0002
536 THROMBOSIS 16 0.0002
537 NEUTROPHIL COUNT DECREASED 8 0.0002
538 HYPOKALAEMIA 9 0.0002
539 LIMB DISCOMFORT 6 0.0002
540 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
541 HYPERBILIRUBINAEMIA 2 0.0002
542 PETECHIAE 2 0.0002
543 HERPES ZOSTER 11 0.0002
544 BRAIN FOG 3 0.0002
545 MUCOSAL INFLAMMATION 5 0.0002
546 PRODUCT ODOUR ABNORMAL 2 0.0002
547 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
548 SKIN CANCER 4 0.0002
549 ANAL ABSCESS 1 0.0002
550 CHEILITIS 1 0.0002
551 FAECES DISCOLOURED 4 0.0002
552 PULMONARY THROMBOSIS 2 0.0002
553 TRANSAMINASES INCREASED 4 0.0002
554 RASH MACULO-PAPULAR 4 0.0002
555 HEART RATE ABNORMAL 1 0.0002
556 INTESTINAL PERFORATION 2 0.0002
557 FISTULA 2 0.0002
558 BLOOD CALCIUM DECREASED 2 0.0002
559 CHOLECYSTITIS ACUTE 1 0.0002
560 SCAB 2 0.0002
561 MYOCARDITIS 2 0.0002
562 EXERCISE TOLERANCE DECREASED 1 0.0002
563 RENAL FAILURE 23 0.0002
564 PERICARDIAL EFFUSION 4 0.0002
565 DECREASED APPETITE 40 0.0002
566 ELECTROLYTE IMBALANCE 2 0.0002
567 EOSINOPHILIA 3 0.0002
568 HYPERCHLORHYDRIA 1 0.0002
569 HEAD DISCOMFORT 3 0.0002
570 ENERGY INCREASED 1 0.0002
571 BRADYKINESIA 1 0.0002
572 BLOOD IRON DECREASED 2 0.0002
573 ODYNOPHAGIA 1 0.0002
574 HYPERLIPIDAEMIA 2 0.0002
575 ABDOMINAL DISCOMFORT 28 0.0002
576 DIABETIC KETOACIDOSIS 4 0.0002
577 GASTROENTERITIS VIRAL 3 0.0002
578 DEHYDRATION 22 0.0002
579 ADRENAL INSUFFICIENCY 2 0.0002
580 END STAGE RENAL DISEASE 3 0.0002
581 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
582 SMALL INTESTINAL OBSTRUCTION 2 0.0002
583 GENERALISED OEDEMA 2 0.0002
584 CHOLANGITIS 1 0.0002
585 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
586 MEMORY IMPAIRMENT 22 0.0002
587 PEMPHIGUS 2 0.0002
588 PLATELET COUNT DECREASED 17 0.0002
589 BLOOD SODIUM DECREASED 3 0.0002
590 COLITIS 6 0.0002
591 INCREASED APPETITE 3 0.0002
592 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
593 HIP FRACTURE 5 0.0002
594 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
595 INCOHERENT 1 0.0002
596 HAEMATOMA 4 0.0002
597 HEPATITIS ACUTE 1 0.0002
598 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
599 HYPOGAMMAGLOBULINAEMIA 1 0.0002
600 STAPHYLOCOCCAL INFECTION 5 0.0002
601 DISORIENTATION 6 0.0002
602 CORONAVIRUS INFECTION 1 0.0002
603 APPETITE DISORDER 1 0.0002
604 NEOPLASM MALIGNANT 10 0.0001
605 CARDIAC DISORDER 14 0.0001
606 GAIT INABILITY 5 0.0001
607 CYTOKINE RELEASE SYNDROME 3 0.0001
608 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
609 PRODUCT PHYSICAL ISSUE 3 0.0001
610 BRONCHIECTASIS 1 0.0001
611 ONYCHOCLASIS 1 0.0001
612 NAUSEA 115 0.0001
613 PRODUCT USE IN UNAPPROVED INDICATION 36 0.0001
614 JOINT EFFUSION 1 0.0001
615 DRUG INTOLERANCE 14 0.0001
616 TREMOR 24 0.0001
617 INTERSTITIAL LUNG DISEASE 7 0.0001
618 LARGE INTESTINE POLYP 1 0.0001
619 DIVERTICULITIS 4 0.0001
620 LARGE INTESTINE PERFORATION 1 0.0001
621 ORAL DISCOMFORT 2 0.0001
622 HUNGER 2 0.0001
623 APHONIA 2 0.0001
624 MASS 2 0.0001
625 LUNG DISORDER 7 0.0001
626 SKIN REACTION 2 0.0001
627 DRUG INEFFECTIVE 187 0.0001
628 PYREXIA 49 0.0001
629 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
630 JOINT INJURY 3 0.0001
631 LIVER FUNCTION TEST INCREASED 3 0.0001
632 PARALYSIS 2 0.0001
633 POOR QUALITY SLEEP 3 0.0001
634 ARTHROPOD BITE 1 0.0001
635 FEELING DRUNK 1 0.0001
636 RASH PAPULAR 3 0.0001
637 FEELING ABNORMAL 32 0.0001
638 THERAPY NON-RESPONDER 6 0.0001
639 DYSPNOEA EXERTIONAL 5 0.0001
640 MUSCULAR WEAKNESS 15 0.0001
641 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
642 HYPERTHERMIA 1 0.0001
643 ASTHENIA 49 0.0001
644 MUSCLE TWITCHING 3 0.0001
645 VOMITING 61 0.0001
646 MULTIPLE ALLERGIES 1 0.0001
647 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
648 HEAD INJURY 4 0.0001
649 GINGIVAL PAIN 1 0.0001
650 FRUSTRATION TOLERANCE DECREASED 1 0.0001
651 MUSCLE DISORDER 1 0.0001
652 CEREBRAL INFARCTION 3 0.0001
653 DECUBITUS ULCER 1 0.0001
654 PHOTOSENSITIVITY REACTION 2 0.0001
655 TREATMENT FAILURE 10 0.0001
656 BLOOD PRESSURE DECREASED 8 0.0001
657 PNEUMONIA ASPIRATION 3 0.0001
658 ABDOMINAL PAIN LOWER 3 0.0001
659 CANDIDA INFECTION 2 0.0001
660 HYPOPHAGIA 3 0.0001
661 HEPATITIS 3 0.0001
662 SCAR 2 0.0001
663 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
664 MUSCLE STRAIN 1 0.0001
665 ORTHOSTATIC HYPOTENSION 2 0.0001
666 HYPOXIA 4 0.0001
667 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
668 EAR INFECTION 3 0.0001
669 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
670 COLITIS ULCERATIVE 5 0.0001
671 GOUT 2 0.0001
672 HEAVY MENSTRUAL BLEEDING 1 0.0001
673 OROPHARYNGEAL DISCOMFORT 1 0.0001
674 OSTEOMYELITIS 2 0.0001
675 HYPERGLYCAEMIA 4 0.0001
676 INCREASED TENDENCY TO BRUISE 1 0.0001
677 IRON DEFICIENCY ANAEMIA 1 0.0001
678 BLOOD GLUCOSE ABNORMAL 2 0.0001
679 WOUND 3 0.0001
680 HEPATIC ENCEPHALOPATHY 1 0.0001
681 NEPHROPATHY 1 0.0001
682 DIARRHOEA HAEMORRHAGIC 1 0.0001
683 HEPATIC CIRRHOSIS 2 0.0001
684 FLATULENCE 6 0.0001
685 INCORRECT DOSE ADMINISTERED 24 0.0001
686 NEUROPATHY PERIPHERAL 10 0.0001
687 FEELING JITTERY 2 0.0001
688 CHOLESTASIS 2 0.0001
689 WEIGHT DECREASED 29 0.0001
690 ATELECTASIS 1 0.0001
691 PRESCRIBED OVERDOSE 2 0.0001
692 DIZZINESS POSTURAL 1 0.0001
693 HAEMORRHOIDS 2 0.0001
694 PLASMA CELL MYELOMA 4 0.0001
695 CHOKING 2 0.0001
696 SPINAL FRACTURE 2 0.0001
697 BRAIN INJURY 1 0.0001
698 APHASIA 3 0.0001
699 SOMNOLENCE 20 0.0001
700 LACRIMATION INCREASED 3 0.0001
701 EMPHYSEMA 1 0.0001
702 BONE MARROW FAILURE 2 0.0001
703 THROMBOCYTOPENIA 11 0.0001
704 MALAISE 43 0.0001
705 PERITONITIS 2 0.0001
706 PANCREATITIS 5 0.0001
707 CYSTITIS 3 0.0001
708 METABOLIC ACIDOSIS 3 0.0001
709 RETCHING 2 0.0001
710 BODY HEIGHT DECREASED 1 0.0001
711 DECREASED ACTIVITY 1 0.0001
712 ABDOMINAL PAIN UPPER 19 0.0001
713 BIPOLAR DISORDER 1 0.0001
714 DIABETES MELLITUS 7 0.0001
715 OESOPHAGITIS 1 0.0001
716 CHOLELITHIASIS 3 0.0001
717 EYE DISORDER 3 0.0001
718 JOINT SWELLING 11 0.0001
719 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
720 GASTROINTESTINAL PAIN 1 0.0001
721 FALL 30 0.0001
722 URINARY RETENTION 3 0.0001
723 INFLUENZA 10 0.0001
724 ORAL PAIN 2 0.0001
725 OCULAR DISCOMFORT 1 0.0001
726 CHOLECYSTECTOMY 1 0.0001
727 LETHARGY 5 0.0001
728 RASH MACULAR 3 0.0001
729 DYSPHAGIA 8 0.0001
730 CHOLECYSTITIS 1 0.0001
731 CONTUSION 8 0.0001
732 DYSPNOEA 47 0.0001
733 LOCALISED INFECTION 2 0.0001
734 CEREBROVASCULAR ACCIDENT 14 0.0001
735 CONDITION AGGRAVATED 25 0.0001
736 OEDEMA PERIPHERAL 10 0.0001
737 NASOPHARYNGITIS 15 0.0001
738 CYST 1 0.0001
739 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
740 INTESTINAL OBSTRUCTION 3 0.0001
741 CELLULITIS 4 0.0001
742 MUSCLE ATROPHY 1 0.0001
743 CONSTIPATION 17 0.0001
744 SEIZURE 9 0.0001
745 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
746 UNRESPONSIVE TO STIMULI 2 0.0001
747 NERVOUSNESS 4 0.0001
748 SEDATION 2 0.0001
749 SPEECH DISORDER 4 0.0001
750 BEDRIDDEN 1 0.0001
751 DISEASE PROGRESSION 9 0.0001
752 GASTRITIS 2 0.0001
753 ORAL CANDIDIASIS 1 0.0001
754 WEIGHT INCREASED 17 0.0001
755 EYE HAEMORRHAGE 1 0.0001
756 CONFUSIONAL STATE 12 0.0001
757 LIMB INJURY 2 0.0001
758 HEPATIC ENZYME INCREASED 5 0.0001
759 SKIN LESION 2 0.0001
760 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
761 RESPIRATORY DISTRESS 2 0.0001
762 MENTAL STATUS CHANGES 2 0.0001
763 BLOOD PRESSURE INCREASED 11 0.0001
764 POLLAKIURIA 3 0.0001
765 BLISTER 4 0.0001
766 DYSPEPSIA 7 0.0001
767 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
768 SLEEP DISORDER 5 0.0001
769 MUSCLE SPASMS 13 0.0001
770 HEPATOCELLULAR INJURY 1 0.0001
771 DIALYSIS 1 0.0001
772 CARDIOGENIC SHOCK 1 0.0001
773 IMPAIRED QUALITY OF LIFE 1 0.0001
774 ACCIDENTAL UNDERDOSE 1 0.0001
775 BALANCE DISORDER 6 0.0001
776 HYPOKINESIA 1 0.0001
777 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
778 FLUID OVERLOAD 1 0.0001
779 GASTROENTERITIS 1 0.0001
780 DYSSTASIA 2 0.0001
781 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
782 ACUTE MYOCARDIAL INFARCTION 2 0.0001
783 COUGH 19 0.0001
784 LIVER DISORDER 3 0.0001
785 PULMONARY OEDEMA 3 0.0001
786 BLOOD POTASSIUM DECREASED 2 0.0001
787 HYPOAESTHESIA ORAL 1 0.0001
788 STOMATITIS 4 0.0001
789 OSTEOPENIA 1 0.0001
790 NEPHROLITHIASIS 3 0.0001
791 FEELING HOT 4 0.0001
792 DEVICE RELATED INFECTION 1 0.0001
793 EMOTIONAL DISORDER 2 0.0001
794 FEMUR FRACTURE 2 0.0001
795 VISUAL IMPAIRMENT 8 0.0001
796 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
797 DISEASE RECURRENCE 3 0.0001
798 COMA 3 0.0001
799 LOSS OF CONSCIOUSNESS 8 0.0001
800 CARDIAC FAILURE 5 0.0001
801 NIGHT SWEATS 2 0.0001
802 LACTIC ACIDOSIS 2 0.0001
803 MUSCLE TIGHTNESS 1 0.0001
804 DRY MOUTH 5 0.0001
805 BACK DISORDER 1 0.0001
806 MULTIPLE FRACTURES 1 0.0001
807 CARDIAC ARREST 5 0.0001
808 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
809 COAGULOPATHY 1 0.0001
810 SKIN DISORDER 2 0.0001
811 BLOOD UREA INCREASED 1 0.0001
812 FACE OEDEMA 1 0.0001
813 ANGER 2 0.0001
814 CIRCULATORY COLLAPSE 1 0.0001
815 THERAPY CESSATION 3 0.0001
816 BLOOD GLUCOSE INCREASED 11 0.0001
817 GASTRIC DISORDER 2 0.0001
818 DELIRIUM 2 0.0001
819 ABDOMINAL DISTENSION 6 0.0001
820 HAEMORRHAGE 6 0.0001
821 HYPERKALAEMIA 2 0.0001
822 DEPRESSED MOOD 3 0.0001
823 LYMPHOCYTE COUNT DECREASED 1 0.0001
824 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
825 INSOMNIA 15 0.0001
826 GALLBLADDER DISORDER 1 0.0001
827 CEREBRAL HAEMORRHAGE 2 0.0001
828 HEADACHE 35 0.0001
829 BONE DISORDER 1 0.0001
830 UNDERDOSE 4 0.0001
831 HAEMATOCHEZIA 3 0.0001
832 EYE SWELLING 2 0.0001
833 DYSARTHRIA 2 0.0001
834 HALLUCINATION 4 0.0001
835 MYALGIA 9 0.0001
836 BLOOD URINE PRESENT 1 0.0001
837 GASTRIC ULCER 1 0.0001
838 PULMONARY EMBOLISM 5 0.0001
839 MUSCULOSKELETAL DISORDER 1 0.0001
840 HERNIA 1 0.0001
841 ATRIAL FIBRILLATION 5 0.0001
842 DYSPHONIA 3 0.0001
843 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
844 CHILLS 6 0.0001
845 PAIN IN EXTREMITY 15 0.0001
846 DISABILITY 1 0.0001
847 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
848 THERAPEUTIC RESPONSE DECREASED 3 0.0000
849 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
850 BODY TEMPERATURE INCREASED 1 0.0000
851 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
852 OSTEOPOROSIS 2 0.0000
853 RASH 21 0.0000
854 DIZZINESS 24 0.0000
855 DERMATITIS 1 0.0000
856 MOUTH ULCERATION 1 0.0000
857 RECTAL HAEMORRHAGE 2 0.0000
858 HYPOACUSIS 2 0.0000
859 RHINORRHOEA 3 0.0000
860 OVERDOSE 10 0.0000
861 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
862 SWELLING FACE 3 0.0000
863 INTENTIONAL PRODUCT MISUSE 4 0.0000
864 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
865 HEPATOTOXICITY 1 0.0000
866 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
867 ADVERSE DRUG REACTION 4 0.0000
868 PANCREATITIS ACUTE 1 0.0000
869 CHROMATURIA 1 0.0000
870 HEART RATE IRREGULAR 1 0.0000
871 SKIN DISCOLOURATION 2 0.0000
872 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
873 CHEST PAIN 8 0.0000
874 COGNITIVE DISORDER 2 0.0000
875 SWELLING 4 0.0000
876 PRODUCTIVE COUGH 2 0.0000
877 GAIT DISTURBANCE 8 0.0000
878 MOBILITY DECREASED 3 0.0000
879 BLOOD PRESSURE FLUCTUATION 1 0.0000
880 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
881 PRURITUS 16 0.0000
882 NEURALGIA 1 0.0000
883 ARTHRALGIA 17 0.0000
884 PAIN 25 0.0000
885 BRONCHITIS 3 0.0000
886 SYNCOPE 4 0.0000
887 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
888 CHRONIC KIDNEY DISEASE 3 0.0000
889 HAEMATEMESIS 1 0.0000
890 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
891 ANAPHYLACTIC SHOCK 1 0.0000
892 DEAFNESS 1 0.0000
893 JOINT STIFFNESS 1 0.0000
894 CARDIAC FAILURE CONGESTIVE 3 0.0000
895 FEAR 1 0.0000
896 PAIN OF SKIN 1 0.0000
897 DISTURBANCE IN ATTENTION 2 0.0000
898 BLOOD BILIRUBIN INCREASED 1 0.0000
899 RASH PRURITIC 2 0.0000
900 MOOD ALTERED 1 0.0000
901 TREATMENT NONCOMPLIANCE 2 0.0000
902 ABNORMAL DREAMS 1 0.0000
903 FEELING COLD 1 0.0000
904 HAEMOPTYSIS 1 0.0000
905 NECK PAIN 2 0.0000
906 OXYGEN SATURATION DECREASED 2 0.0000
907 TOXICITY TO VARIOUS AGENTS 6 0.0000
908 HYPONATRAEMIA 2 0.0000
909 ANXIETY 10 0.0000
910 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
911 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
912 BACK PAIN 8 0.0000
913 ABDOMINAL PAIN 8 0.0000
914 LIVER FUNCTION TEST ABNORMAL 1 0.0000
915 PALPITATIONS 4 0.0000
916 BONE PAIN 2 0.0000
917 NASAL CONGESTION 2 0.0000
918 ASCITES 1 0.0000
919 WHEEZING 2 0.0000
920 IRRITABILITY 2 0.0000
921 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
922 CORONARY ARTERY DISEASE 1 0.0000
923 ILL-DEFINED DISORDER 2 0.0000
924 VERTIGO 2 0.0000
925 ADVERSE EVENT 3 0.0000
926 OROPHARYNGEAL PAIN 3 0.0000
927 NERVOUS SYSTEM DISORDER 1 0.0000
928 DRUG-INDUCED LIVER INJURY 1 0.0000
929 MOOD SWINGS 1 0.0000
930 MOVEMENT DISORDER 1 0.0000
931 DEEP VEIN THROMBOSIS 2 0.0000
932 ALOPECIA 6 0.0000
933 IMPAIRED HEALING 1 0.0000
934 INFUSION RELATED REACTION 2 0.0000
935 URTICARIA 5 0.0000
936 EYE PRURITUS 1 0.0000
937 SINUSITIS 3 0.0000
938 VISION BLURRED 4 0.0000
939 NEOPLASM PROGRESSION 1 0.0000
940 LYMPHADENOPATHY 1 0.0000
941 CRYING 1 0.0000
942 DYSURIA 1 0.0000
943 HEPATIC FUNCTION ABNORMAL 1 0.0000
944 UNEVALUABLE EVENT 2 0.0000
945 ARTHRITIS 2 0.0000
946 PARAESTHESIA 4 0.0000
947 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
948 HYPOTENSION 5 0.0000
949 DEVICE BREAKAGE 1 0.0000
950 BLINDNESS 1 0.0000
951 LUNG NEOPLASM MALIGNANT 1 0.0000
952 OSTEOARTHRITIS 1 0.0000
953 HYPERHIDROSIS 3 0.0000
954 MENTAL DISORDER 1 0.0000
955 MUSCULOSKELETAL STIFFNESS 2 0.0000
956 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
957 MIGRAINE 2 0.0000
958 BLOOD GLUCOSE DECREASED 1 0.0000
959 HYPOGLYCAEMIA 1 0.0000
960 HEART RATE INCREASED 2 0.0000
961 HYPOAESTHESIA 3 0.0000
962 DRY EYE 1 0.0000
963 CHEST DISCOMFORT 2 0.0000
964 INFLAMMATION 1 0.0000
965 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
966 MUSCULOSKELETAL PAIN 1 0.0000
967 HYPERTENSION 4 0.0000
968 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
969 MEDICATION ERROR 1 0.0000
970 EYE PAIN 1 0.0000
971 DEPRESSION 4 0.0000
972 EYE IRRITATION 1 0.0000
973 CATARACT 1 0.0000
974 HYPERSENSITIVITY 3 0.0000
975 AMNESIA 1 0.0000
976 DRY SKIN 2 0.0000
977 ERYTHEMA 3 0.0000
978 INJURY 1 0.0000
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
980 EPISTAXIS 1 0.0000
981 HOT FLUSH 1 0.0000
982 ACNE 1 0.0000
983 INJECTION SITE BRUISING 1 0.0000
984 INJECTION SITE HAEMORRHAGE 1 0.0000
985 INFLUENZA LIKE ILLNESS 1 0.0000
986 MYOCARDIAL INFARCTION 2 0.0000
987 BREAST CANCER 1 0.0000
988 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
989 ASTHMA 1 0.0000